N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance
Authors:
Open Access
- 15 August 1990
- journal article
- Published by American Society of Hematology in Blood
- Vol. 76 (4) , 801-807
Abstract
Point mutations of the N-ras proto-oncogenes have been previously detected in 20% to 60% of samples of acute myelogenous leukemia (AML), but the clinical significance of these mutations is presently unclear. We directly sequenced polymerase chain reaction (PCR) amplified N-ras fragments to determine the frequency of N-ras point mutations in 55 adult patients with de novo AML. Mutations were present in 8 of 55 (15%) patients. These mutations were usually in codon 12, 13, or 61, but one patient had mutations in both codons 13 and 61, and another had an unusual point mutation in N-ras codon 60. A comparison of patients with and without N-ras mutations showed no statistically significant differences in pretreatment clinical variables, response to induction therapy, or survival, except for a possibly higher percentage of FAB M4 subtypes in patients with the N-ras mutation. These data together with previous reports suggest that the presence of N-ras point mutations do not clearly define a unique clinical or biologic subset of AML patients.Keywords
This publication has 7 references indexed in Scilit:
- An lmproved method for directly sequencing PCR-amplified material using dimethyl sulphoxideNucleic Acids Research, 1989
- ras GTPase activating protein: Signal transmitter and signal terminatorCell, 1989
- GTP‐mediated macromolecular interactions: the common features of different systemsThe FASEB Journal, 1988
- RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.Proceedings of the National Academy of Sciences, 1987
- Mutations of the Kirsten-ras proto-oncogene in human preleukaemiaNature, 1987
- A Cytoplasmic Protein Stimulates Normal N- ras p21 GTPase, But Does Not Affect Oncogenic MutantsScience, 1987
- Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemiaNature, 1985